Procyon Advisors LLC grew its holdings in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 11.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,796 shares of the technology company’s stock after purchasing an additional 405 shares during the quarter. Procyon Advisors LLC’s holdings in Veeva Systems were worth $798,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in VEEV. Massachusetts Financial Services Co. MA increased its holdings in Veeva Systems by 64.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,545,451 shares of the technology company’s stock worth $744,084,000 after purchasing an additional 1,392,256 shares during the period. Principal Financial Group Inc. increased its stake in shares of Veeva Systems by 138.9% during the third quarter. Principal Financial Group Inc. now owns 2,179,284 shares of the technology company’s stock worth $457,366,000 after buying an additional 1,267,061 shares during the period. JPMorgan Chase & Co. raised its holdings in Veeva Systems by 73.2% in the third quarter. JPMorgan Chase & Co. now owns 2,558,592 shares of the technology company’s stock valued at $536,972,000 after acquiring an additional 1,081,501 shares in the last quarter. FMR LLC lifted its stake in Veeva Systems by 25.7% in the third quarter. FMR LLC now owns 2,981,244 shares of the technology company’s stock worth $625,674,000 after acquiring an additional 610,021 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec grew its holdings in Veeva Systems by 761.7% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 297,771 shares of the technology company’s stock worth $62,493,000 after acquiring an additional 263,214 shares in the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.
Veeva Systems Stock Up 0.9 %
Shares of NYSE:VEEV opened at $216.67 on Friday. Veeva Systems Inc. has a 52 week low of $170.25 and a 52 week high of $258.93. The company has a 50-day moving average price of $222.31 and a 200 day moving average price of $209.47. The company has a market cap of $35.18 billion, a P/E ratio of 53.50, a PEG ratio of 1.91 and a beta of 0.84.
Analyst Upgrades and Downgrades
View Our Latest Stock Analysis on Veeva Systems
Insider Transactions at Veeva Systems
In related news, SVP Jonathan Faddis sold 1,694 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $230.30, for a total value of $390,128.20. Following the completion of the sale, the senior vice president now owns 8,061 shares in the company, valued at $1,856,448.30. This trade represents a 17.37 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Thomas D. Schwenger sold 1,126 shares of the company’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $240.01, for a total transaction of $270,251.26. Following the transaction, the insider now owns 27,013 shares in the company, valued at $6,483,390.13. The trade was a 4.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 10.50% of the company’s stock.
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Stories
- Five stocks we like better than Veeva Systems
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- How to Invest in Biotech Stocks
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- CD Calculator: Certificate of Deposit Calculator
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.